General Atlantic invests in medical device company Synaptive
Toronto medical device and technology company Synaptive Medical Inc has received a strategic investment from General Atlantic, a U.S. growth equity firm. No financial terms were disclosed. With the investment, David Caluori, a principal at General Atlantic, will join the company's board. Established in 2012, Synaptive develops integrated technologies, such as its BrightMatter neurosurgical products, to support the work of surgeons and hospitals. It said the partnership with General Atlantic will help accelerate commercialization of its solutions in global markets and fund new R&D development. Synaptive is led by President Cameron Piron.
3 November 2016•5 mins read
